Salvage definitive or hypofractionated radiotherapy for oligometastatic recurrence after durvalumab consolidation in limited-stage small-cell lung cancer: a two-case report
{{output}}
The ADRIATIC trial demonstrated that consolidation durvalumab after concurrent chemoradiotherapy (cCRT) improves progression-free survival (PFS) and overall survival (OS) in limited-stage small cell lung cancer (LS-SCLC), establishing a new standard of care. H... ...
